(NASDAQ: XOMA) Xoma Royalty's forecast annual revenue growth rate of 16.88% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 57.01%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Xoma Royalty's revenue in 2025 is $42,909,000.On average, 2 Wall Street analysts forecast XOMA's revenue for 2025 to be $546,886,827, with the lowest XOMA revenue forecast at $497,822,582, and the highest XOMA revenue forecast at $595,951,072. On average, 2 Wall Street analysts forecast XOMA's revenue for 2026 to be $616,294,784, with the lowest XOMA revenue forecast at $558,853,716, and the highest XOMA revenue forecast at $673,735,851.
In 2027, XOMA is forecast to generate $873,582,897 in revenue, with the lowest revenue forecast at $873,582,897 and the highest revenue forecast at $873,582,897.